SBIR/STTR Research Award
Multiplexed Encoded Particle PCR for Rapid Panel Diagnosis of Sexually-Transmitte
Award amount
$176,400Program and phase
SBIR · Phase IAward year
2010Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ELUCIGEL TECHNOLOGIES
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- PHS2010-2
- Topic code
- NIAID
Research abstract
DESCRIPTION (provided by applicant): Sexually-transmitted infections are an epidemic, particularly among adolescents, that could be managed with routine diagnosis and screening. Currently not practical due to cost constraints, there is a need for rapid and reliable assays capable of panel-testing for multiple infections. To this end, we will develop Multiplexed Encoded Particle PCR (mEP-PCR) assays to accurately and rapidly diagnose multiple sexually transmitted diseases (STDs) with a cost-effective, one- pot test. The specific aims for Phase I of this project are to (1) identify three multiplex PCR targets for N. gonorrhoeae, C. trachomatis, and positive control genomic targets, (2) optimize a one-pot assay where PCR and hybridization are carried out in the same tube, and (3) demonstrate simultaneous reproducible screening for N. gonorrhoeae and C. trachomatis in a single simulated specimen. This project could also be extended to impact screening for respiratory disease, diarrheal disease, and bioterror agents. PUBLIC HEALTH RELEVANCE: The aim of this project is to develop a technology capable of detecting multiple sexually transmitted infections (STIs) in a single physiological sample with high sensitivity and specificity at a very low cost. This tool will be enabling for rapid, cost-effective diagnosis of STIs.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail
- A first-in-class product for the clearance of high-risk human papillomaviruses
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- Optimization, Pharmacokinetics, and Efficacy of an IgG Protease for the Treatment of Immune Thrombocytopenia and Other IgG-Mediated Autoimmune Diseases
- Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients